Current Topics in Medicinal Chemistry

Editor-in-Chief

Jia Zhou
Chemical Biology Program
Department of Pharmacology and Toxicology
University of Texas Medical Branch
Galveston, TX
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor



Nitrogen-containing Heterocycle: A Privileged Scaffold for Marketed Drugs promotion: free to download

Volume:21   Issue: 6
Pp: 439-441
Feng Wang, Yongfang Yao, Hai-liang Zhu* and Yinghui Zhang*
DOI: 10.2174/156802662106210304105631
Published on: 08 April, 2021



An Updated Review on SARS-CoV-2 Main Proteinase (MPro): Protein Structure and Small-Molecule Inhibitors

Volume:21   Issue: 6
Pp: 442-460
Dima A. Sabbah*, Rima Hajjo, Sanaa K. Bardaweel and Haizhen A. Zhong
DOI: 10.2174/1568026620666201207095117
Published on: 08 April, 2021




Current Trends in Enzyme Inhibition and Docking Analysis in Drug Design-Part-IV free to download

Volume:21   Issue: 6
Pp: 461-461
Athina Geronikaki
DOI: 10.2174/156802662106210304111713
Published on: 08 April, 2021



Recent Advances in the Development of 1,2,3-Triazole-containing Derivatives as Potential Antifungal Agents and Inhibitors of Lanoster ol 14α-Demethylase

Volume:21   Issue: 6
Pp: 462-506
Michelyne Haroun*, Christophe Tratrat*, Hafedh Kochkar and Anroop B. Nair
DOI: 10.2174/1568026621999201214232018
Published on: 08 April, 2021




Docking Paradigm in Drug Design

Volume:21   Issue: 6
Pp: 507-546
Vladimir B. Sulimov*, Danil C. Kutov, Anna S. Taschilova, Ivan S. Ilin, Eugene E. Tyrtyshnikov and Alexey V. Sulimov
DOI: 10.2174/1568026620666201207095626
Published on: 08 April, 2021




Tuberculosis: An Update on Pathophysiology, Molecular Mechanisms of Drug Resistance, Newer Anti-TB Drugs, Treatment Regimens and Host- Directed Therapies

Volume:21   Issue: 6
Pp: 547-570
Pobitra Borah, Pran K. Deb*, Katharigatta N. Venugopala, Nizar A. Al-Shar’i, Vinayak Singh, Satyendra Deka, Amavya Srivastava, Vinod Tiwari and Raghu P. Mailavaram
DOI: 10.2174/1568026621999201211200447
Published on: 08 April, 2021